Discover the art of fika at this Swedish coffee shop and learn to tell your kanelbullar from your smörgåsar!
She studied at the Konstfack and the Royal Swedish Academy of Fine Arts, both in Stockholm. Her work has been exhibited at the Nationalmuseet and the Moderna Museet in Stockholm, and she has been ...
From Racheal Crowther’s examination into the ethics of care to SAGG Napoli’s immersive archery installation dissecting ...
Moderna Museet has relaunched its collection in three consecutive shows. Systematic art history is out, quasi-messianic individualism is in.
Today, the Starns' works are in the collections of The Museum of Modern Art in New York, the San Francisco Museum of Modern Art, the National Gallery of Victoria in Melbourne, and the Moderna Museet ...
While Sweden’s Ministry of Culture has declared 2006 the Year of Multiculturalism, the Moderna Museet opened ‘The Moderna Exhibition 2006’, an exclusively national salon featuring 49 Swedish artists.
Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines, including the mRNA vaccine for COVID-19 ...
Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech that'll never recover its former glory -- which it built on the success of ...
Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...
Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...
A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.